AZN vs RIGL · P/E 28, $288.38B cap vs P/E 9.1, rev $137.5M
AstraZeneca PLC (AZN) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the AZN and RIGL stock pages for the full models.
Not investment advice.